Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FEMY Femasys	$0.57 +0.6%	$0.86	$0.55 ▼ $1.80	$18.49M	-2.58	329,193 shs	1.04 million shs
RVP Retractable Technologies	$0.83 -0.9%	$0.71	$0.56 ▼ $0.99	$24.76M	1.15	59,025 shs	208,955 shs
SSKN Strata Skin Sciences	$1.77 +1.1%	$2.12	$1.67 ▼ $3.79	$7.30M	0.66	14,999 shs	18,214 shs
VVOS Vivos Therapeutics	$4.20 -8.7%	$4.52	$1.98 ▼ $7.95	$34.52M	7.03	177,701 shs	163,316 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FEMY Femasys	+0.62%	-19.59%	-34.88%	-45.10%	-45.10%
RVP Retractable Technologies	-0.93%	+4.00%	+19.41%	+27.43%	-13.85%
SSKN Strata Skin Sciences	+1.14%	-3.80%	-14.08%	-31.66%	-35.16%
VVOS Vivos Therapeutics	-8.70%	+2.19%	-25.13%	+84.21%	+48.05%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
FEMY Femasys	3.2468 of 5 stars	3.5	3.0	3.2	2.5	0.6
RVP Retractable Technologies	1.8009 of 5 stars	0.0	3.0	3.2	3.3	0.6
SSKN Strata Skin Sciences	2.4113 of 5 stars	3.5	3.0	1.1	1.7	0.6
VVOS Vivos Therapeutics	1.3469 of 5 stars	2.3	4.0	1.6	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FEMY Femasys	3.00	Buy	$7.33	1,184.30% Upside
RVP Retractable Technologies	0.00	N/A	N/A	N/A
SSKN Strata Skin Sciences	3.00	Buy	$6.00	238.98% Upside
VVOS Vivos Therapeutics	2.50	Moderate Buy	$4.82	14.68% Upside

Current Analyst Ratings Breakdown

Latest SSKN, VVOS, RVP, and FEMY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/11/2025	FEMY Femasys	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$12.00 ➝ $8.00
6/25/2025	FEMY Femasys	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00
6/11/2025	FEMY Femasys	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FEMY Femasys	$1.63M	11.41	N/A	N/A	$0.05 per share	11.42
RVP Retractable Technologies	$38.16M	0.65	$0.02 per share	48.25	$3.31 per share	0.25
SSKN Strata Skin Sciences	$33.56M	0.22	N/A	N/A	$0.07 per share	25.29
VVOS Vivos Therapeutics	$14.39M	2.19	N/A	N/A	$0.61 per share	6.89

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FEMY Femasys	-$18.82M	-$0.86	N/A	N/A	N/A	-1,113.72%	-713.74%	-152.60%	11/11/2025 (Estimated)
RVP Retractable Technologies	-$7.01M	-$0.29	N/A	∞	N/A	-41.11%	-17.15%	-9.33%	N/A
SSKN Strata Skin Sciences	-$10.09M	-$2.84	N/A	N/A	N/A	-35.13%	-266.94%	-32.66%	N/A
VVOS Vivos Therapeutics	-$11.14M	-$1.68	N/A	N/A	N/A	-99.49%	-232.76%	-84.30%	N/A

Latest SSKN, VVOS, RVP, and FEMY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/19/2025	Q2 2025	VVOS Vivos Therapeutics	-$0.39	-$0.55	-$0.16	-$0.55	$3.37 million	$3.82 million
8/13/2025	Q2 2025	SSKN Strata Skin Sciences	-$0.27	-$0.60	-$0.33	-$0.60	$8.56 million	$7.70 million
8/8/2025	Q2 2025	FEMY Femasys	-$0.18	-$0.16	+$0.02	-$0.16	$0.80 million	$0.41 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
FEMY Femasys	N/A	N/A	N/A	N/A	N/A
RVP Retractable Technologies	N/A	N/A	N/A	N/A	N/A
SSKN Strata Skin Sciences	N/A	N/A	N/A	N/A	N/A
VVOS Vivos Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FEMY Femasys	0.03	0.89	0.41
RVP Retractable Technologies	0.01	8.57	5.92
SSKN Strata Skin Sciences	49.58	0.98	0.87
VVOS Vivos Therapeutics	1.69	1.05	0.77

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FEMY Femasys	65.27%
RVP Retractable Technologies	7.58%
SSKN Strata Skin Sciences	32.43%
VVOS Vivos Therapeutics	26.35%

Insider Ownership

Company	Insider Ownership
FEMY Femasys	11.54%
RVP Retractable Technologies	57.10%
SSKN Strata Skin Sciences	39.00%
VVOS Vivos Therapeutics	3.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FEMY Femasys	30	32.58 million	28.82 million	Not Optionable
RVP Retractable Technologies	240	29.94 million	13.47 million	Optionable
SSKN Strata Skin Sciences	120	4.17 million	2.54 million	Not Optionable
VVOS Vivos Therapeutics	160	7.51 million	7.28 million	Optionable

SSKN, VVOS, RVP, and FEMY Headlines

Recent News About These Companies

Vivos Therapeutics, Inc. (VVOS) Q2 2025 Earnings Call Transcript

August 22 at 4:05 PM | seekingalpha.com

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q2 2025 Earnings Call Transcript

August 21 at 8:51 AM | msn.com

Vivos Reports 7% Sales Drop

August 21 at 3:50 AM | aol.comA

Vivos Therapeutics, Inc: Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

August 20 at 5:34 AM | finanznachrichten.de

Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

August 19, 2025 | globenewswire.com

Vivos Therapeutics, Inc. Announces Upcoming Release of Second Quarter 2025 Financial Results and Conference Call

August 19, 2025 | quiverquant.comQ

Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call

August 19, 2025 | globenewswire.com

Vivos Therapeutics Delays Q2 2025 10-Q Filing

August 14, 2025 | msn.com

Vivos Therapeutics (VVOS) Projected to Post Earnings on Wednesday

August 12, 2025 | americanbankingnews.com

Vivos Therapeutics (NASDAQ:VVOS) Stock Rating Lowered by Wall Street Zen

August 12, 2025 | americanbankingnews.com

Vivos Therapeutics Adds to Management Team to Support Expansion and Growth

July 30, 2025 | finance.yahoo.com

Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance - Morningstar

July 2, 2025 | morningstar.comM

Vivos Therapeutics Inc. (VVOS) Stock Price Today - WSJ

July 2, 2025 | wsj.com

Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance

July 1, 2025 | taiwannews.com.twT

Vivos Therapeutics stock soars after Medicare approves VidaSleep oral appliance

July 1, 2025 | in.investing.com

Vivos Therapeutics Shares Skyrocket After Medicare Greenlights VidaSleep Oral Device

July 1, 2025 | msn.com

Vivos Therapeutics Secures CMS Approval for VidaSleep™ Oral Appliance, Expanding Access to Sleep Apnea Treatment

July 1, 2025 | quiverquant.comQ

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

June 26, 2025 | finance.yahoo.com

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

June 26, 2025 | globenewswire.com

Vivos Therapeutics, Inc: Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada

June 11, 2025 | finanznachrichten.de

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSKN, VVOS, RVP, and FEMY Company Descriptions

Femasys NASDAQ:FEMY

$0.57 +0.00 (+0.62%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$0.58 +0.01 (+1.23%)

As of 08/22/2025 07:58 PM Eastern

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Retractable Technologies NYSE:RVP

$0.83 0.00 (-0.57%)

As of 08/22/2025 04:00 PM Eastern

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Strata Skin Sciences NASDAQ:SSKN

$1.77 +0.02 (+1.14%)

Closing price 08/22/2025 03:17 PM Eastern

Extended Trading

$1.74 -0.03 (-1.69%)

As of 08/22/2025 07:53 PM Eastern

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

Vivos Therapeutics NASDAQ:VVOS

$4.20 -0.40 (-8.70%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$4.22 +0.02 (+0.48%)

As of 08/22/2025 07:59 PM Eastern

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time